| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.0076 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.0044 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.00089 | 1 |